ArticleWorld journal of gastrointestinal pharmacology and therapeutics2026
Impact of Endocuff addition to real-time computer-aided detection of colorectal neoplasia in a randomised tandem colonoscopy trial.
Article in World journal of gastrointestinal pharmacology and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRisk of post colonoscopy colorectal cancer is related to adenoma miss rate (AMR) during colonoscopy. Artificial intelligence (AI) and Endocuff Vision are tools both used to increase adenoma detection rate (ADR).
aimTo assess whether the combination of AI and Endocuff vision, compared to using AI alone, increases the ADR.
methodsThis is a single-center randomized, tandem colonoscopy trial. Patients with a Boston Bowel Preparation score ≥ 6 with an indication of colorectal cancer screening (78, 91.8%) or polyp surveillance (7, 8.2%) were included from the study.
resultsEighty-five patients were included in total (male: 51; mean age: 63 ± 8 years old). In 39 patients, the initial colonoscopy was performed using AI alone, while in 45 patients, it was carried out with a combination of AI and Endocuff. Colonoscopies without Endocuff were associated with a numerically higher ADR (19/39, 48.7%
conclusionAdding Endocuff to AI-assisted colonoscopy, according to our results, does not lead to increased adenoma detection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.